Purple Innovation Announces Strategic Manufacturing Consolidation and Positive EBITDA Turnaround
By ATTN Desk · Editorial oversight: Sean Han
Introduction
Purple Innovation, Inc. (NASDAQ: PRPL) is a comfort innovation company headquartered in Lehi, Utah. Founded on proprietary GelFlex® Grid technology, the company designs and manufactures sleep products, including mattresses, pillows, cushions, frames, and sheets. Its products are available online at Purple.com, in 60 Purple stores nationwide, and through more than 3,000 retail partners. The company’s Korean name is 퍼플 이노베이션.
Corporate Structure
Purple Innovation employs between 1,001 and 5,000 people across its corporate, manufacturing, and retail operations. The company maintains:
- A corporate headquarters in Lehi, Utah, with four showroom locations.
- An Innovation Center in Draper, Utah, dedicated to research and development.
- A primary mattress production facility in McDonough, Georgia.
Chief Executive Officer Rob DeMartini leads the executive team, while a board of directors includes independent members overseeing governance and strategy.
Sleep Products by Harper Sunday
Recent Developments and News
- August 22, 2024: Purple announced the consolidation of its mattress manufacturing into the McDonough, Georgia facility. Two Utah plants in Salt Lake City and Grantsville will close by the first quarter of 2025. The move is expected to yield $15–20 million in annualized EBITDA benefits beginning in 2025, with restructuring costs estimated between $35–45 million, of which $26–32 million is non-cash.
- December 31, 2024 / March 13, 2025: The company reported fourth-quarter and full-year 2024 results indicating a return to positive adjusted EBITDA. On the same date, Purple’s board initiated a formal review of strategic alternatives—including potential sale, merger, or other transactions—to maximize shareholder value. A special committee of independent directors was formed for this purpose.
- May 30, 2025: The SEC declared effective Purple’s registration statement on Form S-3, enabling the company to issue additional securities as needed for capital raising or refinancing.
Financial and Strategic Analysis
In the fourth quarter of 2024, Purple achieved its first positive adjusted EBITDA in eight quarters and generated positive operating cash flow. Full-year 2024 results reflected ongoing industry challenges alongside strategic cost controls. Key metrics include:
| Metric | Q4 2024 | Q4 2023 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Net Revenue | $129.0 million | $145.9 million | $487.9 million | $510.5 million |
| GAAP Gross Margin | 42.9% (+970 bps) | 33.2% | 37.1% (+350 bps) | 33.6% |
| Adjusted Gross Margin | 44.9% (+810 bps) | 36.8% | 40.3% (+310 bps) | 37.2% |
| Net Loss | $(8.5) million | $(18.3) million | $(97.9) million | $(120.8) million |
| Adjusted EBITDA | $2.9 million | $(9.8) million | $(20.8) million | $(54.7) million |
| Cash & Cash Equivalents (Dec 31) | $29.0 million | $26.9 million | ||
| Inventories (Dec 31) | $56.9 million | $66.9 million |
Strategically, the manufacturing consolidation is aimed at streamlining operations and reinvesting in technology and marketing under the “Path to Premium Sleep” strategy, supporting long-term positive operating cash flow. The board’s review of strategic alternatives indicates consideration of transactions that could enhance shareholder returns.
Market Position and Industry Context
Purple Innovation competes in the premium mattress and sleep-accessory market, differentiated by its GelFlex Grid, which adapts to body movement, balances temperature, and relieves pressure. The company operates a digitally native vertical model with both direct-to-consumer and wholesale channels. Industry trends include pricing pressure, supply-chain volatility, and evolving consumer preferences for premium sleep solutions. Purple’s recognition as a leading brand in customer satisfaction in the bed-in-a-box mattress segment reflects its engagement in a competitive landscape.
TL;DR
By December 31, 2024, Purple will complete the consolidation of manufacturing into Georgia, aiming for $15–20 million in annualized EBITDA improvement. In the fourth quarter of 2024, the company achieved positive adjusted EBITDA of $2.9 million and generated positive cash flow. On March 13, 2025, the board initiated a review of strategic alternatives, while securing SEC clearance on May 30, 2025, for additional securities issuance. The company remains focused on executing its “Path to Premium Sleep” strategy and exploring transactions to enhance shareholder value.